Leonie Krijger Email

Head Marketing . Cellistic

Current Roles

Employees:
87
Revenue:
$13.5M
About
Launched in April 2022, Cellistic specializes in process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The company’s focus and expertise in iPSC generation and differentiation protocol development makes it well-positioned to partner with innovative cell therapy developers to establish novel advanced therapies. With more than a decade of scientific and technical knowledge transfer from sister company Ncardia, Cellistic is uniquely experienced in designing and optimizing manufacturing procedures for iPSCs that deliver quality products at scale. For more information, visit www.cellistic.com.
Cellistic Address
47 Rue Adrienne Bolland
Gosselies, null
bel

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.